Results 71 to 80 of about 1,862,216 (244)

Caracterización de la restenosis de stents coronarios convencionales y liberadores de medicamentos en pacientes incluidos en el registro DRug Eluting STent (DREST) Characterization of conventional coronary stents restenosis and drug eluting stents in patients included in the Drug Eluting Stent Registry (DREST)

Revista Colombiana de Cardiología, 2012
Introducción y objetivos: los stents convencionales presentan tasas de restenosis intrastent entre 10% y 60%, mientras los stents liberadores de fármacos alcanzan el 10%. Para Latinoamérica, no hay reportes de restenosis intrastent en comparación con los
Jorge A Arroyave C, Magda C Cepeda G
doaj  

A drug-free cardiovascular stent functionalized with tailored collagen supports in-situ healing of vascular tissues

Nature Communications
Drug-eluting stent implantation suppresses the excessive proliferation of smooth muscle cells to reduce in-stent restenosis. However, the efficacy of drug-eluting stents remains limited due to delayed reendothelialization, impaired intimal remodeling ...
Haoshuang Wu, Li Yang, Rifang Luo, Li Li, Tiantian Zheng, Kaiyang Huang, Yumei Qin, Xia Yang, Xingdong Zhang, Yunbing Wang   +9 more
doaj   +1 more source

In-Stent Restenosis and a Drug-Coated Balloon: Insights from a Clinical Therapeutic Strategy on Coronary Artery Diseases

Cardiology Research and Practice, 2020
Coronary heart disease is a major cause of death and disability in developed countries. Stent implantation has become an efficacious treatment for a culprit lesion vessel of the coronary artery.
Dai-Min Zhang, Shaoliang Chen
doaj   +1 more source

Detection of Post‐Stent Medial Dissection and White Thrombus Using Hybrid IVUS OCT Imaging may Help Guide Management

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT We present a 66‐year‐old undergoing ostial‐to‐mid right coronary artery (RCA) percutaneous coronary intervention (PCI) lesion proximal to an existing stent in the mid‐to‐distal segment. The patient underwent PCI, with intravascular imaging using the Novasight Hybrid IVUS OCT (Conavi, Toronto, CA) which revealed a proximal edge dissection and ...
Natali Sorajja, Khady N. Fall, Jeffrey W. Moses, Megha Prasad   +3 more
wiley   +1 more source

The future of drug-eluting stents

Pharmacological Research, 2008
This review aims to provide a glimpse into the future of drug-eluting stents (DES). Since their arrival in 2002, DES have transformed the practice of interventional cardiology by drastically reducing restenosis and the need for repeat revascularization.
Kukreja, N, Onuma, Yoshinobu, Daemen, Joost, Serruys, PWJC (Patrick)   +3 more
openaire   +2 more sources

Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study [PDF]

, 2012
Early-generation drug-eluting stents releasing sirolimus (SES) or paclitaxel (PES) are associated with increased risk of very late stent thrombosis occurring >1 year after stent implantation.
Windecker, Stephan, van Domburg, Ron T, Raber, L, Juni, P, Jüni, Peter, Kalesan, Bindu, Stefanini, Giulio G, Wenaweser, Peter, Stefanini, GG, Kalesan, B, Meier, B, Wenaweser, P, Serruys, PWJC (Patrick), Räber, Lorenz, Daemen, Joost, van Domburg, Ron, Windecker, S, Magro, Michael, Meier, Bernhard, Serruys, Patrick W, Onuma, Yoshinobu   +20 more
core   +1 more source

Percutaneous Coronary Intervention With a Drug-Eluting Stent Versus Coronary Artery Bypass Grafting in Patients Receiving Dialysis: A National Study From Taiwan

Kidney Medicine
Rationale & Objective: We aimed to study the comparative effectiveness of percutaneous coronary intervention with drug-eluting stent and coronary artery bypass grafting in patients receiving dialysis.
Szu-Yu Pan, Ju-Yeh Yang, Nai-Chi Teng, Yun-Yi Chen, Shi-Heng Wang, Chien-Lin Lee, Kang-Lung Chen, Yen-Ling Chiu, Shih-Ping Hsu, Yu-Sen Peng, Yung-Ming Chen, Shuei-Liong Lin, Likwang Chen   +12 more
doaj   +1 more source

Efficacy and Safety of Drug-Eluting Stents in the Real World: 8-Year Follow-Up

Arquivos Brasileiros de Cardiologia, 2014
Background: Drug-eluting stents have been used in daily practice since 2002, with the clear advantages of reducing the risk of target vessel revascularization and an impressive reduction in restenosis rate by 50%-70%.
Denise Oliveira Pellegrini, Vitor Osório Gomes, Ricardo Lasevitch, Luis Smidt, Marco Aurélio Azeredo, Priscila Ledur, Rodrigo Bodanese, Leonardo Sinnott, Emílio Moriguchi, Paulo Caramori   +9 more
doaj   +1 more source

High nitrogen stainless steel drug-eluting stent - Assessment of pharmacokinetics and preclinical safety in vivo

Bioactive Materials, 2020
Pharmacokinetic analyses were performed using 20 pigs for 120-days implantation, while one sirolimus-eluting stent was implanted into one of their coronary artery.
Shanshan Chen, Zhifeng Yao, Yongbiao Guan, Hui Yang, M. Babar Shahzad, Yizhe Wu, Bingchun Zhang, Li Shen, Ke Yang   +8 more
doaj   +1 more source

Primary Percutaneous Coronary Intervention Guided by High‐Definition Intravascular Ultrasound (The SPECTRUM Study)

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Limited data are available on the use of intravascular ultrasound (IVUS) in patients presenting with ST‐segment elevation myocardial infarction (STEMI). Aims This study aimed to assess the impact of IVUS‐guided primary percutaneous coronary intervention (PCI).
Frederik T. W. Groenland, Annemieke C. Ziedses des Plantes, Tara Neleman, Jurgen M. R. Ligthart, Karen T. Witberg, Rutger‐Jan Nuis, Jeroen M. Wilschut, Roberto Diletti, Wijnand K. den Dekker, Isabella Kardys, Paul Cummins, Karim D. Mahmoud, Nicolas M. Van Mieghem, Joost Daemen   +13 more
wiley   +1 more source